Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Repaglinide bulk supplier for pharma manufacturers

Repaglinide 0.5 mg, 1 mg, 2 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.5 mg, 1 mg, 2 mg

Reference Brands: Prandin (USA)

Category: Diabetes

Repaglinide tablets (0.5, 1 and 2 mg) are a short-acting insulin secretagogue taken just before each meal for type 2 diabetes, so doses can be skipped if a meal is skipped. The original brand is Prandin (NovoNorm in Europe). PharmaTradz sources it for importers, hospitals and tenders, and shares GMP certificates and CoA before you commit.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Repaglinide? List it or send an offer →

Product Description:

Repaglinide is an oral antidiabetic medication used for the management of type 2 diabetes mellitus and is marketed under brand names including Prandin, Gluconorm, Surepost, and Novonorm, depending on the region. It belongs to the meglitinide class of antihyperglycemic agents and is indicated for use in combination with diet and exercise to improve blood glucose control in adults with type 2 diabetes.

Repaglinide works by stimulating insulin release from the pancreatic β-islet cells in response to meals, helping to reduce postprandial blood glucose spikes. Its rapid onset and short duration of action allow for flexible dosing before meals, making it effective in controlling blood sugar levels while minimizing the risk of prolonged hypoglycemia.

This medication is generally well tolerated, with hypoglycemia being the most common adverse effect, particularly if meals are skipped or carbohydrate intake is insufficient. Repaglinide offers a practical option for patients requiring targeted post-meal glucose control and can be used as part of a comprehensive diabetes management plan under medical supervision. Its widespread global availability under various brand names ensures accessibility for patients in multiple regions.

Repaglinide — third party manufacturing & bulk supply

Repaglinide 0.5 mg, 1 mg, 2 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Repaglinide is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Repaglinide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Repaglinide →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Repaglinide is used to manage blood glucose levels in adults with type 2 diabetes mellitus, particularly to control postprandial hyperglycemia.

Repaglinide is a synthetically manufactured insulin secretagogue that stimulates pancreatic beta cells to release insulin in response to food intake.

The trade name of repaglinide is Prandin.

Prandin is developed and marketed by Novo Nordisk.

The generic name of Repaglinide is repaglinide.

The brand name of Repaglinide is Prandin.

Repaglinide tablets are manufactured in GMP-compliant pharmaceutical facilities, primarily in the USA and EU, depending on the market.

Yes. It is cleared mainly by the liver, so it is an option in moderate to severe kidney impairment with careful dosing.

Gemfibrozil and clopidogrel sharply raise repaglinide levels and the risk of hypoglycaemia; gemfibrozil should not be combined with it.

Yes, as 0.5, 1 and 2 mg tablets from many manufacturers.

Related Products

Pioglitazone Hydrochloride

Strength:
15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Actos (US/EU), Glustin (EU)

View Details
Nateglinide

Strength:
60 mg, 120 mg, 180 mg

Form: Tablets

Reference Brands: Starlix (USA)

View Details
Miglitol

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Glyset (USA), Diastabol (EU)

View Details
Semaglutide Tablets

Strength:
3 mg, 7 mg, 14 mg

Form: Tablets

Reference Brands: Rybelsus

View Details
Insulin Lispro (Humalog) Injectable

Strength:
U-100, U-200

Form: Vials/pens

Reference Brands: Humalog (US); Humalog (EU)

View Details
Premixed Insulins (70/30, 50/50) Injectable

Strength:
U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details
Tirzepatide

Strength:
2.5 mg / 0.5 mL, 5 mg / 0.5 mL

Form: injection (prefilled syringe)

Reference Brands: Mounjaro (USA/EU), Zepbound (USA)

View Details
Pramlintide

Strength:
1000 mcg/mL

Form: injection (prefilled syringe)

Reference Brands: Symlin (USA/EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us